|
CA101653A
(en)
|
1906-08-30 |
1906-10-23 |
Herman Besser |
Mould
|
|
BE794886A
(fr)
*
|
1972-02-22 |
1973-08-02 |
Pfizer |
Acides 6-(alpha-(omega-guanidinoalcanoylamino)acylamino)-penicillaniques
|
|
US3933797A
(en)
*
|
1972-02-22 |
1976-01-20 |
Pfizer Inc. |
6-[α-(ω-QUANIDINOALKANOYLAMIDO)ACYLAMIDO]PENICILLANIC ACIDS
|
|
US3972872A
(en)
|
1974-09-23 |
1976-08-03 |
Pfizer Inc. |
6-[α-(ω-Guanidinoalkanoylamido)acylamido]penicillanic acids
|
|
EP0260118B1
(en)
|
1986-09-10 |
1991-12-04 |
Syntex (U.S.A.) Inc. |
Selective amidination of diamines
|
|
US5676978A
(en)
*
|
1989-02-14 |
1997-10-14 |
Amira, Inc. |
Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
|
|
CA2028593C
(en)
*
|
1989-10-31 |
2007-08-21 |
Douglas R. Brandt |
Stabilized enzyme compositions
|
|
DE4334639A1
(de)
|
1993-10-11 |
1995-04-13 |
Inst Neue Mat Gemein Gmbh |
Verfahren zur Herstellung von TiN-Sinterkörpern und -Schichten
|
|
US5994577A
(en)
|
1994-11-23 |
1999-11-30 |
Larsen; Scott D. |
Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
|
|
DE793646T1
(de)
|
1994-11-23 |
1999-12-30 |
Pharmacia & Upjohn Co., Kalamazoo |
Carboxylierte aminoguanidine zum behandlung von insulin-unabhängigem diabetes mellitus
|
|
JP3745439B2
(ja)
|
1995-07-06 |
2006-02-15 |
花王株式会社 |
皮膚外用剤
|
|
TW453881B
(en)
|
1995-10-16 |
2001-09-11 |
Kao Corp |
Cosmetic composition comprising amide derivatives
|
|
JPH09202710A
(ja)
*
|
1995-11-20 |
1997-08-05 |
Kao Corp |
しわ改善剤
|
|
US5955617A
(en)
|
1996-05-21 |
1999-09-21 |
Pharmacia & Upjohn Company |
Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
|
|
JP4317599B2
(ja)
|
1996-06-26 |
2009-08-19 |
武田薬品工業株式会社 |
徐放性製剤
|
|
WO2000000195A1
(en)
|
1998-06-30 |
2000-01-06 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical composition for the treatment of diabetes
|
|
JP2003501393A
(ja)
|
1999-06-05 |
2003-01-14 |
ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ |
心臓血管細胞増殖を阻害するための方法および組成物
|
|
EP1656945A1
(en)
|
1999-06-05 |
2006-05-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pharmaceutical composition comprising oligoarginine
|
|
US6242491B1
(en)
|
1999-06-25 |
2001-06-05 |
Rima Kaddurah-Daouk |
Use of creatine or creatine compounds for skin preservation
|
|
US20020082448A1
(en)
|
1999-11-08 |
2002-06-27 |
The Upjohn Company |
Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
|
|
JP2004537581A
(ja)
|
2001-08-08 |
2004-12-16 |
メルク エンド カムパニー インコーポレーテッド |
メラニン濃縮ホルモン拮抗物質
|
|
EP1465609A2
(en)
|
2001-11-07 |
2004-10-13 |
Medical Research Council |
Modulation of dopaminergic neurons
|
|
EP1495046A2
(en)
|
2002-01-09 |
2005-01-12 |
Merck & Co., Inc. |
Selective melanin concentrating hormone type 1 receptor agonists
|
|
US20040126366A1
(en)
|
2002-06-04 |
2004-07-01 |
Rima Kaddurah-Daouk |
Methods of treating cognitive dysfunction by modulating brain energy metabolism
|
|
US20120245211A1
(en)
|
2002-06-04 |
2012-09-27 |
Children's Hospital Medical Center |
Methods of Treating Cognitive Dysfunction by Modulating Brain Energy Metabolism
|
|
GB0302882D0
(en)
|
2003-02-07 |
2003-03-12 |
Univ Cardiff |
Improvements in or relating to agents for the treatment of cardiovascular dysfunction and weight loss
|
|
EP1746099A1
(en)
|
2004-12-23 |
2007-01-24 |
DeveloGen Aktiengesellschaft |
Mnk1 or Mnk2 inhibitors
|
|
JP4865251B2
(ja)
|
2005-05-09 |
2012-02-01 |
株式会社 資生堂 |
不全角化抑制剤、毛穴縮小剤及び皮膚外用組成物
|
|
ES2416355T3
(es)
|
2005-08-02 |
2013-07-31 |
Alzchem Ag |
Formulación líquida a base de un componente de ácido guanidinoacético
|
|
WO2008054544A2
(en)
|
2006-05-22 |
2008-05-08 |
Immune Disease Institute, Inc. |
Method for delivery across the blood brain barrier
|
|
WO2008043024A2
(en)
|
2006-10-04 |
2008-04-10 |
Kalypsys, Inc. |
Oral pharmaceutical formulation comprising a sulfonyl bicyclic modulator of ppar for the treatment of disease
|
|
ES2364865T3
(es)
|
2006-12-11 |
2011-09-15 |
Kempharm, Inc. |
Conjugados de ornitina de la anfetamina y procedimientos de fabricación y de utilización de los mismos.
|
|
DE102007004781A1
(de)
|
2007-01-31 |
2008-08-07 |
Alzchem Trostberg Gmbh |
Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
|
|
EP2433655A3
(en)
|
2007-02-08 |
2013-05-15 |
Kempharm, Inc. |
Homoarginine-prodrugs of amphetamine
|
|
CN101848918A
(zh)
|
2007-09-07 |
2010-09-29 |
吉奇亚公司 |
线粒体组合物及其用途
|
|
WO2009098142A1
(en)
|
2008-02-06 |
2009-08-13 |
Helm Ag |
Prasugrel salts with improved properties
|
|
EP2198838B1
(fr)
|
2008-12-19 |
2018-09-05 |
L'Oréal |
Procédé et dispositif d'éclaircissement ou de coloration directe éclaircissante ou d'oxydation des fibres kératiniques en présence d'une composition aqueuse riche en corps gras
|
|
FR2940104B1
(fr)
|
2008-12-19 |
2011-08-19 |
Oreal |
Procede de traitement des cheveux mettant en oeuvre une emulsion directe comprenant un agent oxydant et une composition contenant un agent alcalin
|
|
FR2940077B1
(fr)
|
2008-12-19 |
2012-07-20 |
Oreal |
Procede de coloration eclaircissante de matieres keratiniques mettant en oeuvre une composition anhydre colorante comprenant un agent alcalin et une composition oxydante.
|
|
JP5866137B2
(ja)
|
2009-04-30 |
2016-02-17 |
ロレアル |
アミノトリアルコキシシランまたはアミノトリアルケニルオキシシラン化合物を含む組成物を用いたヒトケラチン繊維の明色化および／または着色ならびに装置
|
|
WO2011031308A1
(en)
*
|
2009-09-09 |
2011-03-17 |
Cytokinetics, Incorporated |
Novel combinations
|
|
EP2477643A1
(en)
|
2009-09-18 |
2012-07-25 |
Novo Nordisk A/S |
Long-acting y2 receptor agonists
|
|
FR2954160B1
(fr)
|
2009-12-22 |
2012-03-30 |
Oreal |
Composition de coloration ou d'eclaircissement comprenant un corps gras et un polymere amphotere
|
|
CN107714703A
(zh)
|
2009-12-31 |
2018-02-23 |
凯姆制药公司 |
喹硫平的氨基酸缀合物、其制备和使用方法
|
|
DE102010012199A1
(de)
|
2010-03-19 |
2011-09-22 |
Fresenius Medical Care Deutschland Gmbh |
Molekular geprägte Polymere für die Eliminierung von Metaboliten
|
|
FR2958161B1
(fr)
|
2010-04-02 |
2012-04-27 |
Oreal |
Procede de traitement des cheveux mettant en oeuvre une emulsion directe comprenant un agent oxydant et une emulsion directe contenant un agent alcalin
|
|
WO2011127933A1
(en)
|
2010-04-16 |
2011-10-20 |
Nuevolution A/S |
Bi-functional complexes and methods for making and using such complexes
|
|
US20110262359A1
(en)
|
2010-04-21 |
2011-10-27 |
Jenkins Thomas E |
Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
|
|
CA2795222A1
(en)
|
2010-04-21 |
2011-10-27 |
Signature Therapeutics, Inc. |
Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
|
|
US20110262355A1
(en)
|
2010-04-21 |
2011-10-27 |
Jenkins Thomas E |
Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
|
|
WO2011133150A1
(en)
|
2010-04-21 |
2011-10-27 |
Pharmacofore, Inc. |
Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
|
|
US20130059914A1
(en)
|
2010-04-21 |
2013-03-07 |
Signature Therapeutics, Inc. |
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
|
|
KR20130060227A
(ko)
|
2010-05-03 |
2013-06-07 |
제넨테크, 인크. |
단백질-함유 제제의 점도 감소에 유용한 조성물 및 방법
|
|
US20130281410A1
(en)
|
2010-05-13 |
2013-10-24 |
University Of Utah Research Foundation |
Methods for the treatment of psychiatric disorders
|
|
EP2399885A1
(en)
|
2010-06-22 |
2011-12-28 |
Ulrich Dietz |
Device and method for solubilizing, separating, removing and reacting carboxylic acids in aqueous or organic solutions by means of micro- or nanoemulsification
|
|
WO2012024611A1
(en)
|
2010-08-20 |
2012-02-23 |
Natural Alternatives International, Inc. |
Methods of treating sarcopenia and frailty
|
|
WO2012047630A2
(en)
|
2010-09-27 |
2012-04-12 |
Martin Teintze |
N-alkyl or n-aryl substituted guanide and biguanide compounds and methods of their use
|
|
US8765115B2
(en)
|
2010-12-01 |
2014-07-01 |
National Institute of Agrobiological Scienses |
Method of treatment of gastrointestinal disorders with IL-10
|
|
WO2012122412A2
(en)
|
2011-03-09 |
2012-09-13 |
Signature Therapeutics, Inc. |
Compositions for reducing risk of adverse events caused by drug-drug interactions
|
|
AU2012225337B2
(en)
|
2011-03-09 |
2016-04-28 |
Signature Therapeutics, Inc. |
Active agent prodrugs with heterocyclic linkers
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
WO2012138214A1
(en)
|
2011-04-08 |
2012-10-11 |
Brewster Lizzy Maritza |
Beta-guanidinopropionic acid for the treatment of hypertension
|
|
WO2012173846A2
(en)
|
2011-06-06 |
2012-12-20 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
CN102850242A
(zh)
*
|
2011-06-27 |
2013-01-02 |
天津天成制药有限公司 |
胍基丙酸硝酸盐的制备方法
|
|
US8427223B2
(en)
|
2011-07-19 |
2013-04-23 |
Lsi Corporation |
Voltage level translator circuit for reducing jitter
|
|
ES2883259T3
(es)
|
2011-07-28 |
2021-12-07 |
Kempharm Inc |
Profármacos de metilfenidato, procesos para la obtención y uso de los mismos
|
|
AR088392A1
(es)
|
2011-10-18 |
2014-05-28 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos
|
|
FR2983407B1
(fr)
|
2011-12-06 |
2014-01-03 |
Oreal |
Composition aqueuse riche en huile et son utilisation dans un procede de coloration d'oxydation ou de decoloration
|
|
HK1205454A1
(en)
|
2012-02-15 |
2015-12-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
CA2862038C
(en)
|
2012-02-15 |
2021-05-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
PL2854764T3
(pl)
|
2012-06-05 |
2019-07-31 |
Neuroderm Ltd |
Kompozycje zawierające apomorfinę i kwasy organiczne oraz ich zastosowania
|
|
EP2864313A1
(en)
|
2012-06-22 |
2015-04-29 |
Basf Se |
Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers
|
|
EP3736022A3
(en)
|
2012-10-31 |
2021-01-20 |
The Rockefeller University |
Treatment and diagnosis of colon cancer
|
|
FR2997846B1
(fr)
|
2012-11-09 |
2023-10-20 |
Oreal |
Composition comprenant un derive dicarbonyle et un acide, le procede de lissage des fibres keratiniques a partir de cette composition
|
|
WO2014138492A1
(en)
|
2013-03-08 |
2014-09-12 |
Solan, LLC |
Methods for fabricating graphite-based structures and devices made therefrom
|
|
CN103288685B
(zh)
*
|
2013-07-03 |
2015-02-18 |
郭礼强 |
一种3-胍基丙酸的制备方法
|
|
US20170056352A1
(en)
|
2015-08-25 |
2017-03-02 |
Rgenix, Inc. |
PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
|
|
WO2018160178A1
(en)
|
2017-03-01 |
2018-09-07 |
Rgenix, Inc. |
Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof
|